Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Baxter
Mallinckrodt
McKinsey
Medtronic
Boehringer Ingelheim

Last Updated: June 29, 2022

CLINICAL TRIALS PROFILE FOR ARTESUNATE


✉ Email this page to a colleague

« Back to Dashboard

505(b)(2) Clinical Trials for Artesunate

This table shows clinical trials for potential 505(b)(2) applications. See the next table for all clinical trials
Trial Type Trial ID Title Status Sponsor Phase Start Date Summary
New Combination NCT00203801 ↗ Combination Antimalarials in Uncomplicated Malaria Completed Global Fund N/A 2002-01-01 The purpose of this study is to study the efficacy of sulfadoxine-pyrimethamine on its own and compare this with efficacy of a new combination antimalarial therapy, either sulphadoxine-pyrimethamine plus artesunate or artemether-lumefantrine.
New Combination NCT00203801 ↗ Combination Antimalarials in Uncomplicated Malaria Completed Medical Research Council, South Africa N/A 2002-01-01 The purpose of this study is to study the efficacy of sulfadoxine-pyrimethamine on its own and compare this with efficacy of a new combination antimalarial therapy, either sulphadoxine-pyrimethamine plus artesunate or artemether-lumefantrine.
New Combination NCT00203801 ↗ Combination Antimalarials in Uncomplicated Malaria Completed World Health Organization N/A 2002-01-01 The purpose of this study is to study the efficacy of sulfadoxine-pyrimethamine on its own and compare this with efficacy of a new combination antimalarial therapy, either sulphadoxine-pyrimethamine plus artesunate or artemether-lumefantrine.
>Trial Type >Trial ID >Title >Status >Phase >Start Date >Summary

All Clinical Trials for Artesunate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00111163 ↗ Intermittent Preventive Treatment With Antimalarials in Kenyan Infants Completed Bill and Melinda Gates Foundation N/A 2004-03-01 The purpose of the study is to see whether antimalarial drugs administered at the time of routine infant vaccinations prevents malaria and anemia in the first year of life.
NCT00111163 ↗ Intermittent Preventive Treatment With Antimalarials in Kenyan Infants Completed Kenya Medical Research Institute N/A 2004-03-01 The purpose of the study is to see whether antimalarial drugs administered at the time of routine infant vaccinations prevents malaria and anemia in the first year of life.
NCT00111163 ↗ Intermittent Preventive Treatment With Antimalarials in Kenyan Infants Completed Centers for Disease Control and Prevention N/A 2004-03-01 The purpose of the study is to see whether antimalarial drugs administered at the time of routine infant vaccinations prevents malaria and anemia in the first year of life.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Artesunate

Condition Name

Condition Name for Artesunate
Intervention Trials
Malaria 101
Malaria, Falciparum 17
Falciparum Malaria 12
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Artesunate
Intervention Trials
Malaria 188
Malaria, Falciparum 80
Malaria, Vivax 15
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Artesunate

Trials by Country

Trials by Country for Artesunate
Location Trials
Mozambique 27
Congo, The Democratic Republic of the 23
Thailand 22
Burkina Faso 22
Kenya 18
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Artesunate
Location Trials
Maryland 6
Ohio 2
Texas 1
Wisconsin 1
District of Columbia 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Artesunate

Clinical Trial Phase

Clinical Trial Phase for Artesunate
Clinical Trial Phase Trials
Phase 4 60
Phase 3 50
Phase 2/Phase 3 11
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Artesunate
Clinical Trial Phase Trials
Completed 161
Recruiting 15
Unknown status 14
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Artesunate

Sponsor Name

Sponsor Name for Artesunate
Sponsor Trials
London School of Hygiene and Tropical Medicine 25
University of Oxford 24
Medicines for Malaria Venture 17
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Artesunate
Sponsor Trials
Other 465
Industry 50
U.S. Fed 36
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Medtronic
Moodys
McKesson
Mallinckrodt
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.